Looking to sell Cellarity stock or options?
Contact usCellarity is a biomedical technology developer that has created a platform designed to digitize molecular information in cells, providing insight into their behavior during health and disease. Cellarity's platform utilizes single-cell technologies and machine learning to digitize and quantify cellular behaviors, decode the network dynamics that control those behaviors, and develop medicines that can guide them. This innovative approach aids companies in enhancing the speed and success rate of drug discovery.
Hanwha Impact, Ahren Innovation Capital, BlackRock, Kyowa Kirin, The Baupost Group, Flagship Pioneering, Hercules Capital, Pictet, Jameel Investment Management Company.